Advertisement
Screener

RadNet, Inc. (RDNT) ROI

RadNet, Inc. ROI

Return on investment (ROI), also called return on invested capital, is the profit a company earns for every dollar of long-term capital from both lenders and shareholders, shown as a percentage. It is net income divided by long-term debt plus shareholder equity, and the table shows both amounts. Because debt is included in the base, ROI does not rise just because a company replaces equity with borrowing, which sets it apart from ROE. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • RadNet, Inc. roi for the quarter ending 2026-06-30 was -0.77%, a change of -0.12% year-over-year.
  • RadNet, Inc. roi for the quarter ending 2026-03-31 was -0.58%, a change of 0.91% year-over-year.
  • RadNet, Inc. roi for the quarter ending 2025-12-31 was -0.75%, a 687.59% decline year-over-year.
  • RadNet, Inc. roi for the quarter ending 2025-09-30 was -0.52%, a change of -0.32% year-over-year.
  • RadNet, Inc. roi for fiscal 2025 was -0.75%, a 687.59% decline from fiscal 2024.
  • RadNet, Inc. roi for fiscal 2024 was 0.13%, a 29.89% decline from fiscal 2023.
  • RadNet, Inc. roi for fiscal 2023 was 0.18%, a 76.68% decline from fiscal 2022.
  • RadNet, Inc. roi for fiscal 2022 was 0.79%, a 64.67% decline from fiscal 2021.
Available history
2011-12-31 to 2026-06-30
Data captured

Historical ROI

DateROINet income 12 monthNet income 3 monthDebt plus equity
2026-06-30-0.77%-$21.12M$7.53M$2.76B
2026-03-31-0.58%-$14.19M-$33.47M$2.47B
2025-12-31-0.75%-$18.65M-$595.00K$2.47B
2025-09-30-0.52%-$12.71M$5.42M$2.44B
2025-06-30-0.65%-$14.92M$14.45M$2.31B
2025-03-31-1.49%-$32.35M-$37.93M$2.17B
2024-12-310.13%$2.79M$5.34M$2.17B
2024-09-30-0.20%-$4.41M$3.21M$2.16B
2024-06-300.46%$9.92M-$2.98M$2.14B
2024-03-311.10%$21.27M-$2.78M$1.93B
2023-12-310.18%$3.04M-$1.86M$1.66B
2023-09-300.24%$3.97M$17.54M$1.67B
2023-06-30-0.79%-$12.9M$8.37M$1.64B
2023-03-31-0.97%-$13.37M-$21.00M$1.38B
2022-12-310.79%$10.65M-$935.00K$1.36B
2022-09-300.64%$7.76M$668.00K$1.22B
2022-06-301.92%$23.32M$7.91M$1.21B
2022-03-311.54%$18.28M$3.01M$1.18B
2021-12-312.22%$24.73M-$3.82M$1.11B
2021-09-303.11%$34.51M$16.22M$1.11B
2020-12-31-1.56%-$14.84M$5.96M$950.8M
2012-12-312.22%$12.39M$56.63M$558.43M
2011-12-311.69%$8.01M$4.55M$473.39M

Annual ROI

DateROINet income 12 monthDebt plus equity
2025-12-31-0.75%-$18.65M$2.47B
2024-12-310.13%$2.79M$2.17B
2023-12-310.18%$3.04M$1.66B
2022-12-310.79%$10.65M$1.36B
2021-12-312.22%$24.73M$1.11B
2020-12-31-1.56%-$14.84M$950.8M
2012-12-312.22%$12.39M$558.43M
2011-12-311.69%$8.01M$473.39M

Similar stocks

Stock NameCountryMarket CapPE Ratio
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70